Filing Details

Accession Number:
0001493152-22-025023
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-02 18:21:53
Reporting Period:
2022-09-01
Accepted Time:
2022-09-02 18:21:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1357459 Palisade Bio Inc. PALI Biological Products, (No Disgnostic Substances) (2836) 522007292
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1851034 David John Finley 7750 El Camino Real,
Suite 5200
Carlsbad, CA 92009
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Acquisiton 2022-09-01 19,481 $0.14 148,727 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.01 38,867 Indirect By FCW Investments, LLC
Footnotes
  1. Reporting Person purchased 19,481.242 shares of Common Stock of Issuer at prices ranging from $0.1437 to $0.1439 with a weighted average price per share of $0.1437 on September 1 2022. The reporting person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer
  2. Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.